Failed trials for central nervous system disorders do not necessarily invalidate preclinical models and drug targets

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Nature reviews. Drug discovery 2016-07, Vol.15 (7), p.516-516
Hauptverfasser:	Bespalov, Anton, Steckler, Thomas, Altevogt, Bruce, Koustova, Elena, Skolnick, Phil, Deaver, Daniel, Millan, Mark J., Bastlund, Jesper F., Doller, Dario, Witkin, Jeffrey, Moser, Paul, O'Donnell, Patricio, Ebert, Ulrich, Geyer, Mark A., Prinssen, Eric, Ballard, Theresa, Macleod, Malcolm
Format:	Artikel
Sprache:	eng
Schlagworte:	631/154/309/2144 692/617/375 Animals Biomedicine Biotechnology Cancer Research Care and treatment Central nervous system diseases Central Nervous System Diseases - drug therapy Clinical trials Clinical Trials as Topic - standards correspondence Drug Evaluation, Preclinical - standards Evaluation Humans Medicinal Chemistry Molecular Medicine Pharmacology/Toxicology Research Design Treatment Failure
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!